Qian-Fei Wang
Overview
Explore the profile of Qian-Fei Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu F, An Z, Cui L, Xiao M, Wu Y, Li W, et al.
Adv Sci (Weinh)
. 2025 Mar;
:e2410417.
PMID: 40040609
Corticosteroids (CSs) are the initial therapy for immune thrombocytopenia (ITP); however, their efficacy is not adequately predicted. As a novel biomarker, the composition of the gut microbiota is non-invasively tested...
2.
Su Y, Han Z, Ji Y, Liu A, Zou D, Yan L, et al.
Leukemia
. 2025 Feb;
PMID: 39894867
Recent pan-cancer analysis revealed the global pattern and potential aetiologies of copy number variation signatures in human cancers, particularly those derived from non-hematopoietic tissues. In sharp contrast, the generally low...
3.
Li Y, Chen K, Wang Q
Front Med
. 2024 Nov;
18(6):988-1001.
PMID: 39542989
Megakaryocytes (MKs), which are traditionally known for their role in platelet production, are now emerging as unique immune cells with diverse capabilities. They express immune receptors, participate in pathogen recognition...
4.
Liu F, Qu Q, Lei Y, Chen Q, Chen Y, Li M, et al.
Sci China Life Sci
. 2024 Apr;
67(8):1635-1647.
PMID: 38644444
To investigate the role of co-stimulatory and co-inhibitory molecules on immune tolerance in immune thrombocytopenia (ITP), this study mapped the immune cell heterogeneity in the bone marrow of ITP at...
5.
Chen L, Liu J, Chen K, Su Y, Chen Y, Lei Y, et al.
J Thromb Haemost
. 2024 Mar;
22(6):1727-1741.
PMID: 38537781
Background: Megakaryocytes (MKs) are polyploid cells responsible for producing ∼10 platelets daily in humans. Unraveling the mechanisms regulating megakaryopoiesis holds the promise for the production of clinical-grade platelets from stem...
6.
Li J, Liu J, Li Y, Chen L, Cheng H, Li Y, et al.
Immunity
. 2024 Mar;
57(3):478-494.e6.
PMID: 38447571
Emerging evidence has revealed a direct differentiation route from hematopoietic stem cells to megakaryocytes (direct route), in addition to the classical differentiation route through a series of restricted hematopoietic progenitors...
7.
Zhang Y, Jiang S, He F, Tian Y, Hu H, Gao L, et al.
Genome Biol
. 2023 Aug;
24(1):199.
PMID: 37653425
Background: Cancer patients can achieve dramatic responses to chemotherapy yet retain resistant tumor cells, which ultimately results in relapse. Although xenograft model studies have identified several cellular and molecular features...
8.
An Z, Wu Y, Hou Y, Mei H, Nong W, Li W, et al.
Sci Bull (Beijing)
. 2023 Aug;
68(18):2106-2114.
PMID: 37599175
Rare but critical bleeding events in primary immune thrombocytopenia (ITP) present life-threatening complications in patients with ITP, which severely affect their prognosis, quality of life, and treatment decisions. Although several...
9.
Lu Y, Sui P, Li J, Lian N, Zhou J, Cheng X, et al.
Toxicol Lett
. 2023 May;
382:33-40.
PMID: 37245849
Benzene is a known hematotoxic and leukemogenic chemical. Exposure to benzene cause inhibition of hematopoietic cells. However, the mechanism of how the hematopoietic cells inhibited by benzene undergo malignant proliferation...
10.